We hypothesize that GDF-15 exerts its effect by inhibiting DC maturation and reducing the expression of surface markers, thereby altering the liver's immune environment and promoting inflammation, which in turn increases the risk of NAFLD. The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatotic liver disease.